Protocol ITANET - Registry

Recruiting now

Conditions studied: Gastro-entero Pancreatic Neuroendocrine Tumors

In brief

This is a prospective observational study with the aim to create an Italian database for the collection of data on diagnostic approach, therapy and follow up of patients affected by GEP-NET (gastro-enteric-pancreatic neuroendocrine tumours). Data for approximately 200 italian patients were already previously collected in the ENETS database (international database). ENETS decided to interrupt the collection of the data for an indefinite period. For this reason, through an amendment (number 1) to the protocol, ITANET (Italian Association Neuro-endocrine Tumors) decided to transfer the italian data into a national database and to go on with the collection/update of the data, in order not to lose important clinical information.

Key facts

Study ID

NCT04282083

Run by

Italian Association Neuroendocrine Tumors

People needed

3600

Starts

2019-05-25

Expected to finish

2032-07-31

Last updated by the study team

2024-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age> or = 18 years;
• histologically/cytologically proved diagnosis of NET OR diagnosis supported by a PET Gallium 68 positivity and by at least a contrastografic imaging of second level (CT scan or NMR);
• Diagnosis of GEP-NET not antecedent 1 year since the Informed Consent signature;
• Grading G1, G2, G3 according to the classification WHO 2019;
• Tumor origin in digestive apparatus (GEP NETs) or tumor of unknown origin;
• Signed Informed consent.

You may not qualify if…

• Known tumor origin different from digestive apparatus (GEP NETs);
• no evidence of histologically/cytologically proved diagnosis of NET OR diagnosis supported by a PET Gallium 68 positivity and by at least a contrastografic imaging of second level (CT scan or NMR);
• Diagnosis of GEP-NET antecedent 1 year since the Informed Consent signature.

Where it is running

• Istituto Clinico Humanitas — Rozzano, Milan, Italy (enrolling)
• Clinica Pederzoli — Peschiera del Garda, Verona, Italy (enrolling)
• AO Ospedali Riuniti — Ancona, Italy (enrolling)
• Azienda Ospedaliera Universitaria Consorziale Policlinico — Bari, Italy (enrolling)
• Azienda Ospedaliera Universitaria Policlinico S. Orsola Malpighi — Bologna, Italy (enrolling)
• IRCCS Azienda Ospedaliera-Universitaria di Bologna — Bologna, Italy (enrolling)
• Ospedale Regionale di Bolzano — Bolzano, Italy (enrolling)
• ASST Spedali Civili — Brescia, Italy (enrolling)
• Presidio Ospedaliero A. Perrino — Brindisi, Italy (enrolling)
• Istituto Oncologico del Mediterraneo — Catania, Italy (enrolling)
• Azienda Ospedaliera Universitaria — Ferrara, Italy (enrolling)
• Ospedale Policlinico S. Martino — Genova, Italy (enrolling)
• Ospedale Santa Maria Goretti — Latina, Italy (enrolling)
• Azienda Ospedaliera Universitaria Policlinico G. Martino — Messina, Italy (enrolling)
• San Raffaele Hospital — Milan, Italy (enrolling)
• IRCCS Istituto Nazionale Tumori — Milan, Italy (enrolling)
• Istituto Europeo di Oncologia — Milan, Italy (enrolling)
• AOU Policlinico-Modena — Modena, Italy (enrolling)
• Ospedale San Gerardo — Monza, Italy (enrolling)
• Istituto Nazionale Tumori IRCCS Fondazione G. Pascale — Naples, Italy (enrolling)
• AO Cardarelli — Naples, Italy (enrolling)
• Policlinico Università Federico II — Naples, Italy (enrolling)
• Istituto Oncologico Veneto IRCCS — Padova, Italy (enrolling)
• Centro di Riferimento Regionale per i Tumori Rari dell'adulto Università degli Studi di Palermo — Palermo, Italy (enrolling)
• Ospedale Santa Chiara — Pisa, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.